ATE439138T1 - Probiotika zur primären prävention atopischer erkrankungen - Google Patents

Probiotika zur primären prävention atopischer erkrankungen

Info

Publication number
ATE439138T1
ATE439138T1 AT01951716T AT01951716T ATE439138T1 AT E439138 T1 ATE439138 T1 AT E439138T1 AT 01951716 T AT01951716 T AT 01951716T AT 01951716 T AT01951716 T AT 01951716T AT E439138 T1 ATE439138 T1 AT E439138T1
Authority
AT
Austria
Prior art keywords
atopic diseases
probiotics
primary prevention
atopic
diseases
Prior art date
Application number
AT01951716T
Other languages
English (en)
Inventor
Erika Isolauri
Seppo Salminen
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8558595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE439138(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE439138T1 publication Critical patent/ATE439138T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01951716T 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen ATE439138T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
PCT/FI2001/000588 WO2001097822A1 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases

Publications (1)

Publication Number Publication Date
ATE439138T1 true ATE439138T1 (de) 2009-08-15

Family

ID=8558595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951716T ATE439138T1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen

Country Status (9)

Country Link
US (2) US7112322B2 (de)
EP (3) EP1296694B1 (de)
AT (1) ATE439138T1 (de)
AU (1) AU784921B2 (de)
DE (2) DE60139554D1 (de)
ES (3) ES2721848T3 (de)
FI (1) FI110668B (de)
PT (2) PT2201955T (de)
WO (1) WO2001097822A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (de) * 2002-05-24 2003-11-26 Nestec S.A. Probiotika und Oraltoleranz
JP4212838B2 (ja) 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
WO2005058335A1 (en) 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1731137A1 (de) * 2005-06-08 2006-12-13 Nestec S.A. Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut
EP1642570A1 (de) 2004-10-04 2006-04-05 L'oreal Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US8021883B2 (en) 2005-05-11 2011-09-20 Chr. Hansen A/S Antibiotic-sensitive lactic acid bacteria strains
JP2009067679A (ja) * 2005-12-27 2009-04-02 Univ Of Tokushima 抗ヒスタミン作用を有する医薬
CA2645472C (en) 2006-03-10 2015-09-15 N.V. Nutricia Use of non-digestable saccharides for giving an infant the best start after birth
US8226936B2 (en) 2006-11-15 2012-07-24 Chr-Hansen A/S Tetracycline-sensitive bifidobacteria strains
WO2008071930A1 (en) 2006-12-11 2008-06-19 Danisco A/S Composition
BRPI0721254A2 (pt) * 2007-02-22 2013-01-15 Juergen Schrezenmeir medicamento para a profilaxia, supressço ou eliminaÇço de reaÇÕes alÉrgicas, medicamento para a troca de balanÇo th1-th2 no corpo humano em direÇço a uma aumento de th1 e/ou a reduÇço de th2, mÉtodo para o preparo de um medicamento para a profilaxia, supressço ou eliminaÇço de reaÇÕes alÉrgicas em humanos, mÉtodo para a produÇço de um medicamento para a troca de balanÇo th1-th2 no corpo humano em direÇço a um aumento de th1 e/ou a uma reduÇço de th2, uso de bactÉria gram-positiva, probiàtica tais como, lactobacilos e bifidobactÈria, e alimento ou suplemento de alimento
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
EP1974734A1 (de) * 2007-03-28 2008-10-01 Nestec S.A. Probiotika zur Minderung des Risikos von Fettleibigkeit
EP1974743A1 (de) * 2007-03-28 2008-10-01 Nestec S.A. Probiotika zur Verbesserung der Darm-Biozönose
US20090007924A1 (en) * 2007-04-30 2009-01-08 Iliff Edwin C Arbiter system and method of computerized medical diagnosis and advice
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
CA2719719A1 (en) 2008-03-28 2009-10-01 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
US20110053889A1 (en) * 2008-09-02 2011-03-03 Joanne Szabo Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
CA2774963A1 (en) * 2009-10-09 2011-04-14 Prothera, Inc. Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
CN102269858A (zh) 2010-06-02 2011-12-07 北京智朗芯光科技有限公司 自动聚焦系统和自动聚焦方法
WO2012000959A1 (en) * 2010-06-30 2012-01-05 Nestec S.A. Use of caftaric acid and lactic bacterium in food or beverages for regulating skin pigmentation
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (de) 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) zur Verwendung mittels perinataler maternaler Verabreichung zur Verringerung und Vorbeugung von Allergien bei den Nachkommen
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
US11446316B2 (en) 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN113662199A (zh) 2011-08-29 2021-11-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
EP2617296A1 (de) * 2012-01-19 2013-07-24 Nestec S.A. Zusammensetzung mit spezifischen Lactobacillus-helveticus-Stämmen und Verringerung von Lebensmittel- und/oder Atemwegsallergiesymptomen
CN110201003A (zh) 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
DK2861242T3 (en) 2012-06-18 2018-10-29 Heinz Co Brands H J Llc GLUTEN RELATED DISORDERS
WO2014052438A1 (en) 2012-09-25 2014-04-03 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
PL2994150T3 (pl) 2013-05-10 2019-09-30 H.J. Heinz Company Brands Llc Probiotyki i sposoby zastosowania
US20150064304A1 (en) * 2013-09-03 2015-03-05 Mario Medri Probiotic lozenge, method of making same, and uses thereof
MX2016005408A (es) * 2013-11-15 2016-08-11 Nestec Sa Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesarea.
WO2015090349A1 (en) 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants
EP2886660A1 (de) * 2013-12-20 2015-06-24 Rigas Tehniska universitate In-situ-Fluoreszenzhybridisierungsverfahren zur Identifizierung eines Mikroorganismus
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
US20160271189A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
CA2950839C (en) * 2016-01-30 2023-09-12 Cooper Technologies Company Equipment rack and components thereof
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
US20220000947A1 (en) * 2018-12-21 2022-01-06 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
MX2023006086A (es) * 2020-11-24 2023-08-07 Johnson & Johnson Consumer Inc Métodos para prevenir, retrasar o aliviar enfermedades atópicas.
WO2024042229A1 (en) 2022-08-25 2024-02-29 Chr. Hansen A/S Bifidobacterium strains with improved stability

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5246591A (en) * 1990-07-13 1993-09-21 Pact, Incorporated Separation of metal ions on an anion exchange resin by chromatographic elution
BE1009359A7 (fr) * 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0904784A1 (de) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
GB9808579D0 (en) 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
JP4010062B2 (ja) * 1998-09-02 2007-11-21 医療法人社団青藍会 アトピー性皮膚炎を防ぐ保健食品
JP2000086524A (ja) 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases

Also Published As

Publication number Publication date
PT2201955T (pt) 2019-11-25
PT1296694E (pt) 2009-10-28
ES2721848T3 (es) 2019-08-05
FI20001460A (fi) 2001-12-21
DE60139554D1 (de) 2009-09-24
FI20001460A0 (fi) 2000-06-20
ES2754797T3 (es) 2020-04-20
ES2329549T3 (es) 2009-11-27
EP1296694A1 (de) 2003-04-02
WO2001097822A1 (en) 2001-12-27
US20030180272A1 (en) 2003-09-25
EP2206507A1 (de) 2010-07-14
AU784921B2 (en) 2006-07-27
AU7257201A (en) 2002-01-02
DE01951716T1 (de) 2005-06-23
EP2206507B1 (de) 2019-03-13
FI110668B (fi) 2003-03-14
US20060013806A1 (en) 2006-01-19
US7988960B2 (en) 2011-08-02
EP2201955A1 (de) 2010-06-30
EP1296694B1 (de) 2009-08-12
EP2201955B1 (de) 2019-08-14
US7112322B2 (en) 2006-09-26

Similar Documents

Publication Publication Date Title
ATE439138T1 (de) Probiotika zur primären prävention atopischer erkrankungen
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
ATE421256T1 (de) Probiotische zusammensetzung
DE60226254D1 (de) Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
HK1081432A1 (en) Antiallergic agent, utilization thereof in the manufacture of a medicament for reducing allergy
DE69930944D1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
DE60133581D1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
DE60222238D1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
ATE439851T1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
WO2005005481A3 (en) Combination therapy for gastroenteric diseases caused by microorganisms
DE60214029D1 (de) Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs
DE69927930D1 (de) Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora
ATE333875T1 (de) Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod
BG105453U (en) Probiotic food additive
TW200611973A (en) Novel microorganism strain GM-090 of lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties